TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $5,412,000 | +932.8% | 201,558 | +1734.2% | 0.02% | +1500.0% |
Q4 2021 | $524,000 | -72.8% | 10,989 | -62.1% | 0.00% | -75.0% |
Q3 2021 | $1,925,000 | -83.1% | 28,981 | -80.1% | 0.00% | -84.6% |
Q2 2021 | $11,374,000 | -36.3% | 145,780 | -22.7% | 0.03% | -43.5% |
Q1 2021 | $17,850,000 | +65.4% | 188,704 | +113.1% | 0.05% | +48.4% |
Q4 2020 | $10,789,000 | +146.9% | 88,545 | +77.0% | 0.03% | +93.8% |
Q3 2020 | $4,370,000 | -16.4% | 50,022 | -38.2% | 0.02% | -38.5% |
Q2 2020 | $5,227,000 | – | 80,925 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |